Pfizer (PFE) EPS (Basic) (QoQ) (2009 - 2026)
Powered by 
Analysis
Pfizer (PFE) EPS (Basic) (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.40 Bn | 620.65 Bn | 17.26 Bn |
| 2 | AbbVie | 446.32 Bn | 439.75 Bn | 12.70 Bn |
| 3 | Merck | 358.11 Bn | 350.97 Bn | 12.21 Bn |
| 4 | Novartis Ag | 268.22 Bn | 260.53 Bn | 11.24 Bn |
| 5 | Pfizer | 156.86 Bn | 145.17 Bn | 10.94 Bn |
| 6 | Sanofi | 52.17 Bn | 44.78 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.03 Bn | 43.03 Bn | - |
| 8 | Incyte | 24.83 Bn | 20.29 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.38 Bn | 18.72 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.87 Bn | 15.48 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | -108.82% |
| Mar 29, 2026 | 264.16% |
| Dec 31, 2025 | -146.21% |
| Sep 28, 2025 | 21.24% |
| Jun 29, 2025 | -1.72% |
| Sep 29, 2024 | 15,797.19% |
| Jun 30, 2024 | -98.47% |
| Mar 31, 2024 | 192.72% |
| Jul 2, 2023 | -58.01% |
| Jul 3, 2022 | 26.49% |
| Oct 3, 2021 | 232.67% |
| Jul 4, 2021 | 14.15% |
| Sep 27, 2020 | 138.30% |
| Jun 28, 2020 | 3.79% |
| Mar 29, 2020 | 690.66% |
| Dec 31, 2019 | -107.41% |
| Sep 29, 2019 | 52.44% |
| Jun 30, 2019 | 31.68% |
| Mar 31, 2019 | 1,158.38% |
| Dec 31, 2018 | -109.30% |